Ayten Tuna, Olcay Boyacioglu, Ayse Dondu, Seda Orenay-Boyacioglu
{"title":"miR-26b, miR-30e和miR-206多态性可能在bdnf介导的阿尔茨海默氏型痴呆的发展中发挥作用。","authors":"Ayten Tuna, Olcay Boyacioglu, Ayse Dondu, Seda Orenay-Boyacioglu","doi":"10.9758/cpn.24.1223","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The brain-derived neurotrophic factor (BDNF) playing a crucial role in neuron survival and function, particularly in neurodegenerative diseases like Alzheimer's disease (AD). Our study seeks to explore polymorphisms in miRNAs that regulate the <i>BDNF</i> gene in individuals with AD, and to reveal the relationship between these polymorphisms and <i>APOE</i> genotypes.</p><p><strong>Methods: </strong>Seventy AD patients who applied to the Psychiatry outpatient clinic were recruited for the study as well as 70 healthy individuals in the same age. The cases were examined for 5 miRNAs regulating <i>BDNF</i> and 2 <i>APOE</i> SNPs using the SNPType method on the Fluidigm platform.</p><p><strong>Results: </strong>In comparisons of the genotype distributions for three polymorphisms (<i>miR-206 rs16882131</i>, <i>miR-30e rs112439044</i>, <i>miR-26b rs188612260</i>) (<i>p</i> < 0.01 all) and the allele frequencies for two polymorphisms (<i>miR-30e rs112439044</i>, <i>miR-26b rs188612260</i>) (<i>p</i> < 0.01) detected significant differences between groups. While the <i>APOE</i> <i>e4/e4</i> genotype was detected in 4.50% of the AD group, no individual with this genotype was observed in the control group. When the correlation between miRNA polymorphisms and <i>APOE</i> genotypic distributions were investigated, the <i>miR-30e rs10489167</i> polymorphism showed a statistically significant positive correlation with the <i>ε2/ε2</i> genotype and a statistically significant negative correlation with the <i>e2/e3</i> genotype (<i>p</i> < 0.08 and <i>p</i> < 0.001, respectively). On the other hand, the <i>miR-30e rs112439044</i> polymorphism exhibited a statistically significant positive correlation with the <i>e2/e2</i> and <i>ε2/ε2</i> genotypes (<i>p</i> < 0.03 and <i>p</i> < 0.07, respectively).</p><p><strong>Conclusion: </strong>These findings could potentially offer insights into the mechanisms underlying AD.</p>","PeriodicalId":10420,"journal":{"name":"Clinical Psychopharmacology and Neuroscience","volume":"23 2","pages":"193-201"},"PeriodicalIF":2.4000,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12000675/pdf/","citationCount":"0","resultStr":"{\"title\":\"<i>miR-26b</i>, <i>miR-30e</i>, and <i>miR-206</i> Polymorphisms May Play a Role in <i>BDNF</i>-mediated Development of Alzheimer's-type Dementia.\",\"authors\":\"Ayten Tuna, Olcay Boyacioglu, Ayse Dondu, Seda Orenay-Boyacioglu\",\"doi\":\"10.9758/cpn.24.1223\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The brain-derived neurotrophic factor (BDNF) playing a crucial role in neuron survival and function, particularly in neurodegenerative diseases like Alzheimer's disease (AD). Our study seeks to explore polymorphisms in miRNAs that regulate the <i>BDNF</i> gene in individuals with AD, and to reveal the relationship between these polymorphisms and <i>APOE</i> genotypes.</p><p><strong>Methods: </strong>Seventy AD patients who applied to the Psychiatry outpatient clinic were recruited for the study as well as 70 healthy individuals in the same age. The cases were examined for 5 miRNAs regulating <i>BDNF</i> and 2 <i>APOE</i> SNPs using the SNPType method on the Fluidigm platform.</p><p><strong>Results: </strong>In comparisons of the genotype distributions for three polymorphisms (<i>miR-206 rs16882131</i>, <i>miR-30e rs112439044</i>, <i>miR-26b rs188612260</i>) (<i>p</i> < 0.01 all) and the allele frequencies for two polymorphisms (<i>miR-30e rs112439044</i>, <i>miR-26b rs188612260</i>) (<i>p</i> < 0.01) detected significant differences between groups. While the <i>APOE</i> <i>e4/e4</i> genotype was detected in 4.50% of the AD group, no individual with this genotype was observed in the control group. When the correlation between miRNA polymorphisms and <i>APOE</i> genotypic distributions were investigated, the <i>miR-30e rs10489167</i> polymorphism showed a statistically significant positive correlation with the <i>ε2/ε2</i> genotype and a statistically significant negative correlation with the <i>e2/e3</i> genotype (<i>p</i> < 0.08 and <i>p</i> < 0.001, respectively). On the other hand, the <i>miR-30e rs112439044</i> polymorphism exhibited a statistically significant positive correlation with the <i>e2/e2</i> and <i>ε2/ε2</i> genotypes (<i>p</i> < 0.03 and <i>p</i> < 0.07, respectively).</p><p><strong>Conclusion: </strong>These findings could potentially offer insights into the mechanisms underlying AD.</p>\",\"PeriodicalId\":10420,\"journal\":{\"name\":\"Clinical Psychopharmacology and Neuroscience\",\"volume\":\"23 2\",\"pages\":\"193-201\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-05-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12000675/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Psychopharmacology and Neuroscience\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.9758/cpn.24.1223\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Psychopharmacology and Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.9758/cpn.24.1223","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
miR-26b, miR-30e, and miR-206 Polymorphisms May Play a Role in BDNF-mediated Development of Alzheimer's-type Dementia.
Objective: The brain-derived neurotrophic factor (BDNF) playing a crucial role in neuron survival and function, particularly in neurodegenerative diseases like Alzheimer's disease (AD). Our study seeks to explore polymorphisms in miRNAs that regulate the BDNF gene in individuals with AD, and to reveal the relationship between these polymorphisms and APOE genotypes.
Methods: Seventy AD patients who applied to the Psychiatry outpatient clinic were recruited for the study as well as 70 healthy individuals in the same age. The cases were examined for 5 miRNAs regulating BDNF and 2 APOE SNPs using the SNPType method on the Fluidigm platform.
Results: In comparisons of the genotype distributions for three polymorphisms (miR-206 rs16882131, miR-30e rs112439044, miR-26b rs188612260) (p < 0.01 all) and the allele frequencies for two polymorphisms (miR-30e rs112439044, miR-26b rs188612260) (p < 0.01) detected significant differences between groups. While the APOEe4/e4 genotype was detected in 4.50% of the AD group, no individual with this genotype was observed in the control group. When the correlation between miRNA polymorphisms and APOE genotypic distributions were investigated, the miR-30e rs10489167 polymorphism showed a statistically significant positive correlation with the ε2/ε2 genotype and a statistically significant negative correlation with the e2/e3 genotype (p < 0.08 and p < 0.001, respectively). On the other hand, the miR-30e rs112439044 polymorphism exhibited a statistically significant positive correlation with the e2/e2 and ε2/ε2 genotypes (p < 0.03 and p < 0.07, respectively).
Conclusion: These findings could potentially offer insights into the mechanisms underlying AD.
期刊介绍:
Clinical Psychopharmacology and Neuroscience (Clin Psychopharmacol Neurosci) launched in 2003, is the official journal of The Korean College of Neuropsychopharmacology (KCNP), and the associate journal for Asian College of Neuropsychopharmacology (AsCNP). This journal aims to publish evidence-based, scientifically written articles related to clinical and preclinical studies in the field of psychopharmacology and neuroscience. This journal intends to foster and encourage communications between psychiatrist, neuroscientist and all related experts in Asia as well as worldwide. It is published four times a year at the last day of February, May, August, and November.